Fig. 3 | Scientific Reports

Fig. 3

From: Potentiation of immune checkpoint blockade with an ITPP radiosensitizer studied with oxygen saturation measurements from photoacoustic imaging

Fig. 3

ITPP promoted ICB rejection of CT26 tumors. (a) A study timeline. ICB was administered 3 h after ITPP. (b) Tumor growth kinetics and (c) survival data of Balb/cJ mice bearing subcutaneously implanted CT26 tumors and receiving the indicated treatments. *p < 0.0332, **p < 0.0021, ***p < 0.0002, ****p < 0.0001. (d) Individual tumor growth kinetics within each respective treatment group showing the number of tumors rejected. Values are shown as average, and error bars represent standard error of the mean. n = 4–5, with three biological repeats.

Back to article page